C-Terminal modification of polytheonamide B uncouples its dual functions in MCF-7 cancer cells

Yun-Wei Xue1, Kensuke Miura1, Hiroaki Itoh1

  • 1Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. inoue@mol.f.u-tokyo.ac.jp.

Chemical Communications (Cambridge, England)
|March 15, 2023
PubMed

Insights

Polytheonamide B, a large peptide, exhibits cytotoxicity against cancer cells by disrupting cell membranes and neutralizing lysosomes. Researchers created new analogues to separate these two distinct ion transport functions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Polytheonamide B is a large peptide with potent cytotoxicity against MCF-7 cancer cells.
  • Its cytotoxicity stems from two distinct ion transport functions: plasma membrane depolarization and lysosome neutralization.

Purpose of the Study:

  • To understand the specific contributions of each ion transport function to Polytheonamide B's cytotoxicity.
  • To design and synthesize novel analogues of Polytheonamide B with uncoupled functions.

Main Methods:

  • Synthesis of Polytheonamide B analogues.
  • Characterization of ion transport activities (membrane depolarization, lysosome neutralization).
  • Assessment of cytotoxicity against MCF-7 cancer cells.

Main Results:

  • Successful design and synthesis of Polytheonamide B analogues.
  • Demonstration of uncoupling the membrane depolarization and lysosome neutralization functions.
  • Identification of analogues with selective activity.

Conclusions:

  • The two ion transport functions of Polytheonamide B can be pharmacologically separated.
  • This uncoupling provides insights into the mechanism of action and potential for targeted cancer therapy.